Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Request a free trial

No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: dofetilide

« Back to Dashboard
Dofetilide is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has forty-nine patent family members in forty-four countries.

There is one drug master file entry for dofetilide. One supplier is listed for this compound.

Summary for Generic Name: dofetilide

Drug Master File Entries: see list1
Suppliers / Packaging: see list9
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: dofetilide

Drug ClassAntiarrhythmic

Clinical Trials for: dofetilide

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
CAPSULE;ORAL020931-002Oct 1, 1999RXNo6,124,363<disabled><disabled>
CAPSULE;ORAL020931-001Oct 1, 1999RXNo6,124,363<disabled><disabled>
CAPSULE;ORAL020931-003Oct 1, 1999RXYes6,124,363<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: dofetilide

Country Document Number Publication Date
Algeria2632Mar 08, 2003
Iceland5426Mar 31, 2000
Australia737668Aug 30, 2001
African Intellectual Property Organization (OAPI)11350Dec 17, 2003
Guatemala199800165Apr 19, 2000
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn